Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,378 | -59,731 | -42,113 | -24,319 | -11,090 |
| Depreciation Amortization | 4,704 | 19,798 | 14,768 | 9,323 | 4,571 |
| Income taxes - deferred | N/A | -6,425 | -7,811 | -5,420 | -2,064 |
| Accounts receivable | 886 | 4,945 | 4,064 | 4,685 | 3,076 |
| Accounts payable and accrued liabilities | -9,330 | 2,060 | 425 | -3,458 | -4,626 |
| Other Working Capital | -6,405 | 3,814 | 2,984 | 958 | -3,216 |
| Other Operating Activity | 13,789 | 42,942 | 35,940 | 20,290 | 9,942 |
| Operating Cash Flow | $-14,734 | $7,403 | $8,257 | $2,059 | $-3,407 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,595 | 12,111 | 9,274 | 7,727 | 8,440 |
| PPE Investments | -39 | -887 | -1,437 | -1,056 | -838 |
| Purchase Of Investment | -10,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -8,217 | -13,122 | -9,632 | -6,278 | -3,477 |
| Other Investing Activity | -8,217 | 34,378 | 37,868 | 41,222 | -3,477 |
| Investing Cash Flow | $-20,851 | $45,602 | $45,705 | $47,893 | $4,125 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,864 | 11,732 | 11,340 | 3,003 | 1,964 |
| Other Financing Activity | -7,566 | -6,287 | -7,256 | -4,754 | -1,818 |
| Financing Cash Flow | $-2,702 | $5,445 | $4,084 | $-1,751 | $146 |
| Exchange Rate Effect | 10 | -58 | -57 | 63 | 4 |
| Beginning Cash Position | 99,394 | 41,002 | 41,002 | 41,002 | 41,002 |
| End Cash Position | 61,117 | 99,394 | 98,991 | 89,266 | 41,870 |
| Net Cash Flow | $-38,277 | $58,392 | $57,989 | $48,264 | $868 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,734 | 7,403 | 8,257 | 2,059 | -3,407 |
| Capital Expenditure | -39 | -887 | -1,437 | -1,056 | -838 |
| Free Cash Flow | -14,773 | 6,516 | 6,820 | 1,003 | -4,245 |